Blog
Analysts Estimate Evergy Inc (EVRG) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when Evergy Inc (EVRG) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
Expedia (EXPE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Expedia (EXPE) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Doximity (DOCS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook
Epam (EPAM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Epam (EPAM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is
Datadog (DDOG) Expected to Beat Earnings Estimates: Should You Buy?
Datadog (DDOG) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Analysts Estimate Krispy Kreme (DNUT) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Krispy Kreme (DNUT) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Crinetics Pharmaceuticals, Inc. (CRNX) reports results for the quarter ended June 2025. While this widely-known
Crocs (CROX) Reports Next Week: Wall Street Expects Earnings Growth
Crocs (CROX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
The market expects Collegium Pharmaceutical (COLL) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended June 2025. This
Lincoln Electric (LECO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, Lincoln Electric Holdings (LECO) reported revenue of $1.09 billion, up 6.6% over the same period last year. EPS came in at $2.60, compared to $2.34 in the year-ago
Compared to Estimates, Kellanova (K) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Kellanova (K) reported revenue of $3.2 billion, up 0.3% over the same period last year. EPS came in at $0.94, compared to $1.01 in the year-ago quarter.
The reported
Compared to Estimates, Sirius XM (SIRI) Q2 Earnings: A Look at Key Metrics
Sirius XM (SIRI) reported $2.14 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 1.8%. EPS of $0.57 for the same period compares to $0.80 a year ago.
The
Insight Enterprises (NSIT) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Insight Enterprises (NSIT) reported revenue of $2.09 billion, down 3.3% over the same period last year. EPS came in at $2.45, compared to $2.46 in the year-ago
MasterCard (MA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, MasterCard (MA) reported revenue of $8.13 billion, up 16.8% over the same period last year. EPS came in at $4.15, compared to $3.59 in the year-ago quarter.
The
Compared to Estimates, Roblox (RBLX) Q2 Earnings: A Look at Key Metrics
Roblox (RBLX) reported $1.44 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 50.5%. EPS of -$0.41 for the same period compares to -$0.32 a year ago.
The
First Foundation (FFWM) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, First Foundation (FFWM) reported revenue of $51.42 million, down 10.6% over the same period last year. EPS came in at -$0.09, compared to $0.06 in the year-ago
Best Momentum Stocks to Buy for July 31st
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:
Newmont Corporation NEM: This producer and explorer of gold and other metals has a
Sprouts Farmers Beats on Q2 Earnings With 10.2% Jump in Comp Sales
Sprouts Farmers Market, Inc. SFM reported better-than-expected second-quarter 2025 results, wherein the top and bottom lines increased year over year. Decent comparable sales, positive traffic
Cactus Q2 Earnings Miss, Revenues Fall Year Over Year
Cactus, Inc. WHD reported second-quarter 2025 adjusted earnings of 66 cents per share, which missed the Zacks Consensus Estimate of 67 cents. The bottom line declined from the year-ago quarter’s
ETFs to Buy as Microsoft Nears $4T Mark Post Blowout Q4 Earnings
Microsoft (MSFT) spread optimism on Wall Street after reporting blowout fourth-quarter fiscal 2025 results. It beat earnings and revenue estimates, driven by its cloud computing and artificial
Air Products' Earnings and Revenues Surpass Estimates in Q3
Air Products and Chemicals, Inc. APD logged third-quarter fiscal 2025 (ended June 30, 2025) earnings from continuing operations of $3.24 per share, up from $3.13 recorded in the year-ago
Does Zevra Therapeutics (ZVRA) Have the Potential to Rally 117.11% as Wall Street Analysts Expect?
Shares of Zevra Therapeutics (ZVRA) have gained 16.8% over the past four weeks to close the last trading session at $10.99, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet
Shares of uniQure (QURE) have gained 1.3% over the past four weeks to close the last trading session at $14.46, but there could still be a solid upside left in the stock if short-term price targets




